©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 21, 2014; 20(39): 14381-14392
Published online Oct 21, 2014. doi: 10.3748/wjg.v20.i39.14381
Published online Oct 21, 2014. doi: 10.3748/wjg.v20.i39.14381
Table 1 Treatment options for hepatocellular carcinoma within injured liver
| Local ablation therapy | Only for small tumors (in size and number) |
| Liver resection | Most available and efficient treatment |
| Applicable to < 30% of all HCC patients | |
| 5-yr survival of 38%-61% depending on the tumor stage | |
| 80% of patients recur within five years after resection | |
| Liver transplantation | Ideal treatment for removal of existing tumor and underlying injured/preneoplastic tissue |
| Tumor progression while on waiting list | |
| Patients with advanced/extensive HCC have very poor outcomes |
- Citation: Morise Z, Kawabe N, Tomishige H, Nagata H, Kawase J, Arakawa S, Yoshida R, Isetani M. Recent advances in the surgical treatment of hepatocellular carcinoma. World J Gastroenterol 2014; 20(39): 14381-14392
- URL: https://www.wjgnet.com/1007-9327/full/v20/i39/14381.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i39.14381